RNU7-133P

Across TCGA pan-cancer cohorts, RNU7-133P RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated RNU7-133P data layer.

The strongest signal is observed in uterine carcinosarcoma (UCS), where higher RNU7-133P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU7-133P expression acts as an unfavorable survival marker.

UCS, SKCM, and COAD are the cancer types where RNU7-133P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCS	DFS	Tertile	All	0.068	0.524	<.001	144	view →
SKCM	OS	Tertile	II,III,IV	0.398	0.748	.001	57	view →
COAD	OS	Tertile	IV	0.223	0.682	.001	48	view →
BLCA	OS	Tertile	IV	0.074	0.599	<.001	36	view →
LIHC	OS	Tertile	All	0.158	0.691	.001	36	view →
ACC	DFS	Tertile	II,III,IV	0.084	0.460	.005	33	view →
STAD	DFS	Tertile	IV	0.083	0.379	.001	9	view →
PRAD	OS	Tertile	All	0.932	0.990	.009	6	view →
DLBC	DFS	Median	IV	0.195	0.923	.038	5	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

RNU7-133P–UCS (DFS)

Open the UCS breakdown →